Roivant Sciences (ROIV) Gross Margin (2020 - 2025)
Roivant Sciences (ROIV) posted Gross Margin of 83.19% for Q4 2025, down 10.49% on a QoQ basis from 92.93% in Q3 2025, and down 1353.0% year-over-year from 6.64% in Q4 2024.
Roivant Sciences (ROIV) Gross Margin (2020 - 2025) Analysis & Trends
Roivant Sciences' Gross Margin history runs 6 years deep, the most recent figure standing at 83.19% for Q4 2025.
- Quarterly Gross Margin fell 1353.0% year-over-year to 83.19% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 93.75% (down 182.0% YoY) and the FY2026 annual result came in at 84.44%, down 1242.0% from the prior year.
- Gross Margin was 83.19% for Q4 2025 at Roivant Sciences, down from 92.93% in the prior quarter.
- Across five years, Gross Margin topped out at 97.33% in Q2 2024 and bottomed at 54.38% in Q3 2021.
- A 5-year average of 83.81% and a median of 90.41% in 2021 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2022 — Gross Margin tumbled 3037 bps — and 2023, when it jumped 2294 bps.
- Roivant Sciences' Gross Margin stood at 81.53% in 2021, then slipped by 10 bps to 73.59% in 2022, then gained by 28 bps to 94.08% in 2023, then increased by 3 bps to 96.71% in 2024, then slipped by 14 bps to 83.19% in 2025.
- Business Quant data shows ROIV's Gross Margin at 83.19% in Q4 2025, 92.93% in Q3 2025, and 92.9% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 88.95% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 90.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 83.19% |
| Sep 30, 2025 | 92.93% |
| Jun 30, 2025 | 92.90% |
| Dec 31, 2024 | 96.71% |
| Sep 30, 2024 | 94.77% |
| Jun 30, 2024 | 97.33% |
| Dec 31, 2023 | 94.08% |
| Sep 30, 2023 | 93.89% |
| Jun 30, 2023 | 80.51% |
| Dec 31, 2022 | 73.59% |
| Sep 30, 2022 | 70.95% |
| Jun 30, 2022 | 60.04% |
| Dec 31, 2021 | 81.53% |
| Sep 30, 2021 | 54.38% |
| Jun 30, 2021 | 90.41% |
| Dec 31, 2020 | 88.10% |
| Sep 30, 2020 | 45.96% |
| Jun 30, 2020 | 88.58% |